Trials / Conditions / Von Willebrand Disease, Type 3
Von Willebrand Disease, Type 3
4 registered clinical trials studyying Von Willebrand Disease, Type 3 — 4 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Study to Assess the Efficacy and Safety of Emicizumab in Participants With Type 3 Von Willebrand Disease NCT06998524 | Hoffmann-La Roche | Phase 3 |
| Recruiting | An Observational Study of Participants With Type 3 Von Willebrand Disease on Prophylactic Standard-of-Care Tre NCT06883240 | Hoffmann-La Roche | — |
| Recruiting | Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A NCT05500807 | Bleeding and Clotting Disorders Institute Peoria, Illinois | Phase 1 |
| Enrolling By Invitation | Early Check: Expanded Screening in Newborns NCT03655223 | RTI International | — |